Vlad Coric is of Revance Therapeutics, Inc.. Currently has a direct ownership of 0 shares of RVNC, which is worth approximately $0. The most recent transaction as insider was on Feb 06, 2025, when has been sold 15,000 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 0
100.0% 3M change
100.0% 12M change
Total Value Held $0

Vlad Coric Transaction History

Date Transaction Value Shares Traded Shares Held Form
Feb 06 2025
SELL
Sale (or disposition) back to the issuer
-
15,000 Reduced 100.0%
0 Common Stock
Feb 04 2025
SELL
Disposition due to a tender of shares in a change of control transaction
$21,111 $3.65 p/Share
5,784 Reduced 27.83%
15,000 Common Stock
May 01 2024
BUY
Grant, award, or other acquisition
-
15,000 Added 41.92%
20,784 Common Stock
May 03 2023
BUY
Grant, award, or other acquisition
-
589 Added 9.24%
5,784 Common Stock
Mar 01 2023
BUY
Grant, award, or other acquisition
-
5,195 Added 50.0%
5,195 Common Stock

Also insider at

BHVN
Biohaven Pharmaceutical Holding Co Ltd. Healthcare
BHVN
Biohaven Ltd.
VC

Vlad Coric

New Haven, CT

Track Institutional and Insider Activities on RVNC

Follow Revance Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells RVNC shares.

Notify only if

Insider Trading

Get notified when an Revance Therapeutics, Inc. insider buys or sells RVNC shares.

Notify only if

News

Receive news related to Revance Therapeutics, Inc.

Track Activities on RVNC